---
layout: post
title: "Discussion Paper: Artificial Intelligence in Drug Manufacturing, Notice; Request for Information and Comments; Reopening of the Comment Period"
date: 2026-02-05 18:56:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-20902
original_published: 2023-09-27 00:00:00 +0000
significance: 8.00
---

# Discussion Paper: Artificial Intelligence in Drug Manufacturing, Notice; Request for Information and Comments; Reopening of the Comment Period

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 27, 2023 00:00 UTC
**Document Number:** 2023-20902

## Summary

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice, published in the Federal Register of March 1, 2023, establishing a public docket and requesting information and comments. FDA is reopening the comment period to update comments and to receive any new information.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/27/2023-20902/discussion-paper-artificial-intelligence-in-drug-manufacturing-notice-request-for-information-and)
- API: https://www.federalregister.gov/api/v1/documents/2023-20902

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
